1,8-Dihydroxy-3-methylanthraquinone
SIGMA/229075 - 98%
Synonym: 3-Methylchrysazin; Chrysophanic acid
CAS Number: 481-74-3
Empirical Formula (Hill Notation): C15H10O4
Molecular Weight: 254.24
EC Number: 207-572-2
MDL Number: MFCD00001208
Linear Formula: C15H10O4
Product Type: Chemical
| antibiotic activity spectrum | neoplastics |
| viruses | |
| assay | 98% |
| color | yellow-orange |
| form | crystalline |
| InChI | 1S/C15H10O4/c1-7-5-9-13(1 |
| InChI key | LQGUBLBATBMXHT-UHFFFAOYSA |
| mode of action | enzyme | inhibits |
| Quality Level | 100 ![]() |
| SMILES string | Cc1cc(O)c2C(=O)c3c(O)cccc |
| solubility | chloroform: 1% |
| Application: | Chrysophanic acid, a natural anthraquinone, is used to study anticancer activity in EGFR-overexpressing SNU-C5 human colon cancer cells . It is also used to study the inhibition of replication of poliovirus types 2 and 3 (Picornaviridae) in vitro . |
| Biochem/physiol Actions: | Anticancer activity for chrysophanic acid is via the EGFR/mTOR mediated signaling transduction pathway . Chrysophanic acid has two hydrophobic positions on the molecule (C-6 and the methyl group attached to C-3) which are responsible for the compound′s activity against poliovirus . |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place. |
| Packaging: | 1 g in glass bottle |
| Packaging: | 50 mg in glass insert |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 98% |
| UNSPSC | 51102829 |


